SCHEMBL12984377

SCHEMBL12984377

CSCC[C@H](NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(C)=O)[C@@H](C)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 3/20 0.55
▸ CTSS P25774 3/20 0.55
▸ CTSK P43235 3/20 0.55
▸ CTSH P09668 1/20 0.55
▸ RAMP3 O60896 4/20 0.52
▸ CALCR P30988 4/20 0.52
▸ OPRM1 P35372 7/20 0.52
▸ OPRK1 P41145 6/20 0.52
▸ MAPK8 P45983 1/20 0.51
▸ MAPK9 P45984 1/20 0.51
▸ MAPK10 P53779 1/20 0.51
▸ IL23R Q5VWK5 1/20 0.51
▸ OPRD1 P41143 1/20 0.50
▸ EPHA2 P29317 1/20 0.50
▸ NMUR2 Q9GZQ4 1/20 0.50
▸ NMUR1 Q9HB89 1/20 0.50
▸ MC4R P32245 1/20 0.50
▸ MC5R P33032 1/20 0.50
▸ MC3R P41968 1/20 0.50
▸ MC1R Q01726 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065575 0.96 CTSL (0.55) CTSLCTSSCTSKCTSHRAMP3
SCHEMBL14096140 0.91 RAMP3 (0.60) CTSLCTSSCTSKCTSHRAMP3
SCHEMBL13028975 0.89 RAMP3 (0.65) CTSLCTSSCTSKCTSHRAMP3
SCHEMBL31014198 0.88 MAPK8 (0.56) CTSLCTSSCTSKCTSHCALCR
SCHEMBL30248733 0.88 MAPK8 (0.58) CALCRMAPK8MAPK9MAPK10NMUR2
SCHEMBL30248429 0.86 MAPK8 (0.62) CALCRMAPK8MAPK9MAPK10IL23R
SCHEMBL31014203 0.86 MAPK8 (0.60) CTSLCTSSCTSKCTSHCALCR
SCHEMBL25027403 0.85 MAPK8 (0.53) CALCRMAPK8MAPK9MAPK10IL23R
SCHEMBL25028492 0.84 MAPK8 (0.53) CTSLCTSSCTSKCTSHCALCR
SCHEMBL25028399 0.83 MAPK8 (0.53) CTSLCTSSCTSKCTSHCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100316563-A1 Method For The Preparation Of New Oligoclonal Antibodies BRACCO IMAGING S.P.A. (IT) 2010-12-16 — — US disclosed
US-20100316563-A1 Method For The Preparation Of New Oligoclonal Antibodies BRACCO IMAGING S.P.A. (IT) 2010-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100316563-A1 Method For The Preparation Of New Oligoclonal Antibodies APOB, APOL1, FCGR3B CTSL 1350/4885CTSS 1244/4885CTSK 1539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback